Literature DB >> 25695218

Recent insights emerging from malignant mesothelioma genome sequencing.

Michele Carbone1, Giovanni Gaudino, Haining Yang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25695218      PMCID： PMC4336947          DOI： 10.1097/JTO.0000000000000466

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  15 in total

1.  Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.

Authors:  Wei Li; Jonathan Cooper; Lu Zhou; Chenyi Yang; Hediye Erdjument-Bromage; David Zagzag; Matija Snuderl; Marc Ladanyi; C Oliver Hanemann; Pengbo Zhou; Matthias A Karajannis; Filippo G Giancotti
Journal:  Cancer Cell       Date:  2014-07-14       Impact factor: 31.743

2.  High Incidence of Somatic BAP1 alterations in sporadic malignant mesothelioma.

Authors:  Masaki Nasu; Mitsuru Emi; Sandra Pastorino; Mika Tanji; Amy Powers; Hugh Luk; Francine Baumann; Yu-An Zhang; Adi Gazdar; Shreya Kanodia; Maarit Tiirikainen; Erin Flores; Giovanni Gaudino; Michael J Becich; Harvey I Pass; Haining Yang; Michele Carbone
Journal:  J Thorac Oncol       Date:  2015-04       Impact factor: 15.609

3.  Targeted next-generation sequencing of cancer genes in advanced stage malignant pleural mesothelioma: a retrospective study.

Authors:  Marco Lo Iacono; Valentina Monica; Luisella Righi; Federica Grosso; Roberta Libener; Simona Vatrano; Paolo Bironzo; Silvia Novello; Loredana Musmeci; Marco Volante; Mauro Papotti; Giorgio V Scagliotti
Journal:  J Thorac Oncol       Date:  2015-03       Impact factor: 15.609

4.  High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas.

Authors:  A B Bianchi; S I Mitsunaga; J Q Cheng; W M Klein; S C Jhanwar; B Seizinger; N Kley; A J Klein-Szanto; J R Testa
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

5.  Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma.

Authors:  Guangwu Guo; Juliann Chmielecki; Chandra Goparaju; Adriana Heguy; Igor Dolgalev; Michele Carbone; Sara Seepo; Matthew Meyerson; Harvey I Pass
Journal:  Cancer Res       Date:  2014-12-08       Impact factor: 12.701

6.  BAP1 protein is a progression factor in malignant pleural mesothelioma.

Authors:  Lisa Arzt; Franz Quehenberger; Iris Halbwedl; Thomas Mairinger; Helmut H Popper
Journal:  Pathol Oncol Res       Date:  2013-08-22       Impact factor: 3.201

Review 7.  The cancer genome.

Authors:  Michael R Stratton; Peter J Campbell; P Andrew Futreal
Journal:  Nature       Date:  2009-04-09       Impact factor: 49.962

8.  Autodeubiquitination protects the tumor suppressor BAP1 from cytoplasmic sequestration mediated by the atypical ubiquitin ligase UBE2O.

Authors:  Nazar Mashtalir; Salima Daou; Haithem Barbour; Nadine N Sen; Jessica Gagnon; Ian Hammond-Martel; Haider H Dar; Marc Therrien; El Bachir Affar
Journal:  Mol Cell       Date:  2014-04-03       Impact factor: 17.970

9.  Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer.

Authors:  Y Sekido; H I Pass; S Bader; D J Mew; M F Christman; A F Gazdar; J D Minna
Journal:  Cancer Res       Date:  1995-03-15       Impact factor: 12.701

10.  Evaluation of clonal origin of malignant mesothelioma.

Authors:  Sabahattin Comertpay; Sandra Pastorino; Mika Tanji; Rosanna Mezzapelle; Oriana Strianese; Andrea Napolitano; Francine Baumann; Tracey Weigel; Joseph Friedberg; Paul Sugarbaker; Thomas Krausz; Ena Wang; Amy Powers; Giovanni Gaudino; Shreya Kanodia; Harvey I Pass; Barbara L Parsons; Haining Yang; Michele Carbone
Journal:  J Transl Med       Date:  2014-12-04       Impact factor: 5.531
View more
  5 in total

1.  High-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesothelioma.

Authors:  Yoshie Yoshikawa; Mitsuru Emi; Tomoko Hashimoto-Tamaoki; Masaki Ohmuraya; Ayuko Sato; Tohru Tsujimura; Seiki Hasegawa; Takashi Nakano; Masaki Nasu; Sandra Pastorino; Agata Szymiczek; Angela Bononi; Mika Tanji; Ian Pagano; Giovanni Gaudino; Andrea Napolitano; Chandra Goparaju; Harvey I Pass; Haining Yang; Michele Carbone
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-09       Impact factor: 11.205

2.  A novel PDX modeling strategy and its application in metabolomics study for malignant pleural mesothelioma.

Authors:  Zhongjian Chen; Chenxi Yang; Zhenying Guo; Siyu Song; Yun Gao; Ding Wang; Weimin Mao; Junping Liu
Journal:  BMC Cancer       Date:  2021-11-17       Impact factor: 4.430

3.  A subset of microRNAs defining the side population of a human malignant mesothelioma cell line.

Authors:  Myung-Chul Kim; Na-Yon Kim; Yu-Ri Seo; Yongbaek Kim
Journal:  Oncotarget       Date:  2017-06-27

4.  The genomics of desmoplastic small round cell tumor reveals the deregulation of genes related to DNA damage response, epithelial-mesenchymal transition, and immune response.

Authors:  Andrea Devecchi; Loris De Cecco; Matteo Dugo; Donata Penso; Gianpaolo Dagrada; Silvia Brich; Silvia Stacchiotti; Marialuisa Sensi; Silvana Canevari; Silvana Pilotti
Journal:  Cancer Commun (Lond)       Date:  2018-11-28

Review 5.  Malignant Pleural Mesothelioma: Genetic and Microenviromental Heterogeneity as an Unexpected Reading Frame and Therapeutic Challenge.

Authors:  David Michael Abbott; Chandra Bortolotto; Silvia Benvenuti; Andrea Lancia; Andrea Riccardo Filippi; Giulia Maria Stella
Journal:  Cancers (Basel)       Date:  2020-05-07       Impact factor: 6.639
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.